Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 9, Number 2—February 2003

Research

Using Hospital Antibiogram Data To Assess Regional Pneumococcal Resistance to Antibiotics

Cheryl R. Stein*, David J. Weber*, and Meera Kelley*Comments to Author 
Author affiliations: *The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Main Article

Table 1

Streptococcus pneumoniae susceptibility to nine antimicrobial agents, North Carolina, 1996–2000

Year Percent of all isolates susceptible toa
Penicillin Erythromycin Cefotaxime Levofloxacin Tmp-smxb Tetracycline Clindamycin Vancomycin Chloram-phenicol
1996
65 (18; 1,854)
78 (4; 488)
85(9; 985)
100 (1; 205)
64 (5; 626)
96 (2; 254)
90(4; 492)
100 (7; 580)
93 (2; 381)
1997
63 (24; 2,406)
69 (11; 786)
80 (13; 1,272)
100 (1; 283)
57 (11; 786)
79 (4; 66)
76 (7; 655)
100 (11; 903)
95 (3; 117)
1998
56 (33; 2,827)
64 (17; 1,095)
83 (20; 1,970)
92 (4; 237)
51 (16; 975)
83 (10; 402)
88 (11; 606)
100 (19; 1202)
89 (10; 520)
1999
54 (36; 3,562)
61 (20; 1,397)
80 (22; 2,062)
94 (5; 525)
51 (16; 1,068)
84 (10; 406)
85 (13; 1,017)
100 (21; 1308)
92 (9; 540)
2000 52 (42; 3,497) 61 (27; 1,762) 77 (27; 2,296) 98 (12; 822) 50 (20; 1,292) 81 (14; 717) 88 (18; 1,238) 100 (26; 1,648) 94 (12; 730)

aValues in parentheses are number of hospitals contributing data and total number of isolates reported, respectively

bTmp-smx, trimethoprim-sulfamethoxazole

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO